Cyanine3 NHS ester minimal dye
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 1B041 | 5 nmol | $85.00 | in stock | |
| 2B041 | 10 nmol | $140.00 | in stock | |
| 3B041 | 25 nmol | $210.00 | in stock |
Cyanine3 NHS ester dye for protein labeling, and analog of Cy3® minimal dye.
This reagent is specially quantified - each package contains specified amount of NHS ester with quantity variation within 10%.
Recommended protocol
Customers also purchased with this product
Cyanine3 NHS ester
Amine-reactive Cyanine3 dye NHS ester.Sulfo-Cyanine3 NHS ester
Water soluble sulfo-Cyanine3 SE activated ester for amino-biomolecule labeling.Cyanine3 carboxylic acid
Free Cyanine3 carboxylic acid.General properties
| Appearance: | red solid |
| Quality control: | NMR 1H, HPLC-MS, functional testing |
| Storage conditions: | Storage: 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation maximum, nm: | 555 |
| Emission maximum, nm: | 570 |
| CF260: | 0.04 |
| CF280: | 0.09 |
Product citations
- Romanova, Y.; Laikov, A.; Markelova, M.; Khadiullina, R.; Makseev, A.; Hasanova, M.; Rizvanov, A.; Khaiboullina, S.; Salafutdinov, I. Proteomic Analysis of Human Serum from Patients with Chronic Kidney Disease. Biomolecules, 2020, 10(2), 257. doi: 10.3390/biom10020257
- Baniulis, D.; Sirgėdienė, M.; Haimi, P.; Tamošiūnė, I.; Danusevičius, D. Constitutive and Cold Acclimation-Regulated Protein Expression Profiles of Scots Pine Seedlings Reveal Potential for Adaptive Capacity of Geographically Distant Populations. Forests, 2020, 11(1), 89. doi: 10.3390/f11010089
- Kirectepe Aydin, A.; Özgüler, Y.; Uçar, D.; Kasap, M.; Akpınar, G.; Seyahi, E.; Tahir Turanli, E. Peripheral blood mononuclear cell proteome profile in Behçet's syndrome. Rheumatology International, 2020, 40(1), 65–74. doi: 10.1007/s00296-019-04417-2
- Dietl, A.; Winkel, I.; Pietrzyk, G.; Paulus, M.; Bruckmann, A.; Schröder, J.A.; Sossalla, S.; Luchner, A.; Maier, L.S.; Birner, C. Skeletal muscle alterations in tachycardia-induced heart failure are linked to deficient natriuretic peptide signalling and are attenuated by RAS-/NEP-inhibition. PloS One, 2019, 14, e0225937. doi: 10.1371/journal.pone.0225937
Cy® is a trademark of GE Healthcare.
Purchase of these products does not imply transfer of license to perform methods patented by Carnegie Mellon University and covered by US patents 6,043,025, 6,127,134, 6,246,190, 7566,544, and 7,598,047 "Difference gel electrophoresis using matched multiple dyes" and family members in Australia, Canada, Europe and Japan.
The count of items is incorrect.
Your cart is empty
$ 
